Health Affairs, 25, no. 5 (2006): 1318 doi: 10.1377/hlthaff.25.5.1318 © 2006 by Project HOPE	New Online   House Health Reform Bill   Paying for Reform   Vetting AHIP's Report   HIV/AIDS Costs   Brief: Insurance Reform   HA Blog Top 10

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation Related Collections Access To Care Insurance Coverage Managed Care Managed Care - Consumers Business Of Health Pharmaceuticals Chronic Care Quality Of Care Research And Technology Health Spending Consumer Issues Insurance Market

Specialty Drugs

PROLOGUE

Specialty Drug Management

The ascendance of chronic disease in the U.S. health care "profile" has been widely reported in recent years. Statistics from the Centers for Disease Control and Prevention (CDC) tell us that upward of 70 percent of annual U.S. deaths are directly attributable to chronic diseases, including cardiovascular disease, cancer, and diabetes. Any lingering doubt about the level of policy horsepower that should be devoted to grappling with managing chronic disease should be dispelled by the staggering statistic that more than 75 percent of the annual U.S. medical care bill can be laid at the feet of these disease states. Beyond . . . [Full Text of this Article]

                      What's this?